Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Journal of the American College of Cardiology
|
September 26, 2009
Cardiovascular event risk: high-density lipoprotein and paraoxonase
H Robert Superko
Circulation
|
July 31, 2015
Nontraditional Markers of Cardiovascular Disease Risk Can Improve the 2013 American College of Cardiology/American Heart Association Prevention Guidelines: Insights From the Multi-Ethnic Study of Atherosclerosis Investigation
H Robert Superko
Circulation
|
May 6, 2009
Advanced lipoprotein testing and subfractionation are clinically useful
H Robert Superko
The American Heart Hospital Journal
|
April 9, 2005
Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals
H Robert Superko
Journal of Clinical Lipidology
|
March 6, 2025
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report
H Robert Superko, Brenda Garrett
Circulation
|
January 30, 2008
Lipid management to reduce cardiovascular risk: a new strategy is required
H Robert Superko, Spencer King
Circulation
|
March 10, 2010
Letter by Superko and King regarding article, "Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals"
H Robert Superko, Spencer King
Current Treatment Options in Cardiovascular Medicine
|
April 11, 2003
Hypercholesterolemia and Dyslipidemia: Issues for the Clinician
H. Robert Superko, Nicolas A. Chronos
Current Atherosclerosis Reports
|
August 19, 2008
Is it LDL particle size or number that correlates with risk for cardiovascular disease?
H Robert Superko, Radhika R Gadesam
Progress in Cardiovascular Nursing
|
November 6, 2002
Small LDL and its clinical importance as a new CAD risk factor: a female case study
H Robert Superko, Mary Nejedly, Brenda Garrett
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Journal of the American College of Cardiology
|
September 26, 2009
Cardiovascular event risk: high-density lipoprotein and paraoxonase
H Robert Superko
Circulation
|
July 31, 2015
Nontraditional Markers of Cardiovascular Disease Risk Can Improve the 2013 American College of Cardiology/American Heart Association Prevention Guidelines: Insights From the Multi-Ethnic Study of Atherosclerosis Investigation
H Robert Superko
Circulation
|
May 6, 2009
Advanced lipoprotein testing and subfractionation are clinically useful
H Robert Superko
The American Heart Hospital Journal
|
April 9, 2005
Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals
H Robert Superko
Journal of Clinical Lipidology
|
March 6, 2025
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report
H Robert Superko, Brenda Garrett
Circulation
|
January 30, 2008
Lipid management to reduce cardiovascular risk: a new strategy is required
H Robert Superko, Spencer King
Circulation
|
March 10, 2010
Letter by Superko and King regarding article, "Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals"
H Robert Superko, Spencer King
Current Treatment Options in Cardiovascular Medicine
|
April 11, 2003
Hypercholesterolemia and Dyslipidemia: Issues for the Clinician
H. Robert Superko, Nicolas A. Chronos
Current Atherosclerosis Reports
|
August 19, 2008
Is it LDL particle size or number that correlates with risk for cardiovascular disease?
H Robert Superko, Radhika R Gadesam
Progress in Cardiovascular Nursing
|
November 6, 2002
Small LDL and its clinical importance as a new CAD risk factor: a female case study
H Robert Superko, Mary Nejedly, Brenda Garrett
Page
of 4